BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 26627497)

  • 1. Evaluation of a follow-up protocol for patients on chloroquine and hydroxychloroquine treatment.
    Sanabria MR; Toledo-Lucho SC
    Arch Soc Esp Oftalmol; 2016 Jan; 91(1):10-4. PubMed ID: 26627497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinal toxicity associated with hydroxychloroquine and chloroquine: risk factors, screening, and progression despite cessation of therapy.
    Michaelides M; Stover NB; Francis PJ; Weleber RG
    Arch Ophthalmol; 2011 Jan; 129(1):30-9. PubMed ID: 21220626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Diagnostic Utility of Multifocal Electroretinography in Detecting Chloroquine and Hydroxychloroquine Retinal Toxicity.
    Tsang AC; Ahmadi S; Hamilton J; Gao J; Virgili G; Coupland SG; Gottlieb CC
    Am J Ophthalmol; 2019 Oct; 206():132-139. PubMed ID: 31078540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progression of hydroxychloroquine toxic effects after drug therapy cessation: new evidence from multimodal imaging.
    Mititelu M; Wong BJ; Brenner M; Bryar PJ; Jampol LM; Fawzi AA
    JAMA Ophthalmol; 2013 Sep; 131(9):1187-97. PubMed ID: 23887202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxychloroquine and chloroquine retinopathy: a systematic review evaluating the multifocal electroretinogram as a screening test.
    Tsang AC; Ahmadi Pirshahid S; Virgili G; Gottlieb CC; Hamilton J; Coupland SG
    Ophthalmology; 2015 Jun; 122(6):1239-1251.e4. PubMed ID: 25824328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid Onset of Retinal Toxicity From High-Dose Hydroxychloroquine Given for Cancer Therapy.
    Leung LS; Neal JW; Wakelee HA; Sequist LV; Marmor MF
    Am J Ophthalmol; 2015 Oct; 160(4):799-805.e1. PubMed ID: 26189086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fundus autofluorescence and mfERG for early detection of retinal alterations in patients using chloroquine/hydroxychloroquine.
    Kellner U; Renner AB; Tillack H
    Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3531-8. PubMed ID: 16877425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Maculopathy in Patients Using Hydroxychloroquine.
    Uğurlu A; Aslanova M; Cebeci Z; Kır Mercül N
    Turk J Ophthalmol; 2019 Jun; 49(3):149-153. PubMed ID: 31245977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy.
    Marmor MF; Kellner U; Lai TY; Lyons JS; Mieler WF;
    Ophthalmology; 2011 Feb; 118(2):415-22. PubMed ID: 21292109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the revised american academy of ophthalmology guidelines regarding hydroxychloroquine screening on actual practice.
    Browning DJ
    Am J Ophthalmol; 2013 Mar; 155(3):418-428.e1. PubMed ID: 23218706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disparity between visual fields and optical coherence tomography in hydroxychloroquine retinopathy.
    Marmor MF; Melles RB
    Ophthalmology; 2014 Jun; 121(6):1257-62. PubMed ID: 24439759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroxychloroquine and chloroquine retinopathy: screening for drug toxicity.
    Browning DJ
    Am J Ophthalmol; 2002 May; 133(5):649-56. PubMed ID: 11992862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of screening procedures in hydroxychloroquine toxicity.
    Marmor MF
    Arch Ophthalmol; 2012 Apr; 130(4):461-9. PubMed ID: 22159170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of structural and functional changes in patients screened for hydroxychloroquine retinopathy.
    Greenstein VC; Amaro-Quireza L; Abraham ES; Ramachandran R; Tsang SH; Hood DC
    Doc Ophthalmol; 2015 Feb; 130(1):13-23. PubMed ID: 25502494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinal toxicity related to hydroxychloroquine in patients with systemic lupus erythematosus and rheumatoid arthritis.
    Telek HH; Yesilirmak N; Sungur G; Ozdemir Y; Yesil NK; Ornek F
    Doc Ophthalmol; 2017 Dec; 135(3):187-194. PubMed ID: 28852896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case Report: Hydroxychloroquine Retinopathy.
    Eldeeb M; Chan EW; Omar A
    Optom Vis Sci; 2018 Jun; 95(6):545-549. PubMed ID: 29787487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular toxicity due to chloroquine and hydroxychloroquine: electrophysiological and visual function correlates.
    Tzekov R
    Doc Ophthalmol; 2005 Jan; 110(1):111-20. PubMed ID: 16249962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subjective and objective screening tests for hydroxychloroquine toxicity.
    Cukras C; Huynh N; Vitale S; Wong WT; Ferris FL; Sieving PA
    Ophthalmology; 2015 Feb; 122(2):356-66. PubMed ID: 25444344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Variability of chloroquine and hydroxychloroquine retinopathy among various ethnicities].
    Giocanti-Aurégan A; Couturier A; Girmens JF; Le Mer Y; Massamba N; Barreau E; Audo I;
    J Fr Ophtalmol; 2018 Apr; 41(4):363-367. PubMed ID: 29678344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of different screening methods for chloroquine/hydroxychloroquine retinopathy: multifocal electroretinography, color vision, perimetry, ophthalmoscopy, and fluorescein angiography.
    Missner S; Kellner U
    Graefes Arch Clin Exp Ophthalmol; 2012 Mar; 250(3):319-25. PubMed ID: 22215255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.